BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23451745)

  • 1. Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology.
    Matkowskyj KA; Chen ZE; Rao MS; Yang GY
    Arch Pathol Lab Med; 2013 Mar; 137(3):338-50. PubMed ID: 23451745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic precursor lesions related to the development of cancer in inflammatory bowel disease.
    Harpaz N
    Gastroenterol Clin North Am; 2007 Dec; 36(4):901-26, vii-viii. PubMed ID: 17996797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of nonpolypoid (flat and depressed) colorectal neoplasms in screening for CRC in patients with IBD.
    Rutter MD
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):327-35. PubMed ID: 24975524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation.
    Svrcek M; Borralho Nunes P; Villanacci V; Beaugerie L; Rogler G; De Hertogh G; Tripathi M; Feakins R;
    J Crohns Colitis; 2018 Nov; 12(12):1486-1498. PubMed ID: 30202940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory bowel disease and colorectal cancer].
    Hisamatsu T
    Nihon Rinsho; 2014 Jan; 72(1):56-62. PubMed ID: 24597349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of dysplasia and cancer in inflammatory bowel disease.
    Itzkowitz SH
    Gastroenterol Clin North Am; 2006 Sep; 35(3):553-71. PubMed ID: 16952740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of dysplasia and cancer in inflammatory bowel disease.
    Mescoli C; Frego M; Rugge M
    Ann Ital Chir; 2011; 82(1):11-8. PubMed ID: 21657150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase.
    Toll AD; Boman BM; Palazzo JP
    Hum Pathol; 2012 Feb; 43(2):238-42. PubMed ID: 21820149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
    Shergill AK; Farraye FA
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histological diagnosis of dysplastic and neoplastic lesions in inflammatory bowel disease: a pathological perspective.
    Usaj S; Tarabar D; Cuk V; Cerovic S; Brajukovic G; Panisic M; Klem I; Eric Z
    Acta Chir Iugosl; 2004; 51(2):109-16. PubMed ID: 15771301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associated neoplastic disease in inflammatory bowel disease.
    Cendan JC; Behrns KE
    Surg Clin North Am; 2007 Jun; 87(3):659-72. PubMed ID: 17560418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis.
    Harpaz N; Polydorides AD
    Arch Pathol Lab Med; 2010 Jun; 134(6):876-95. PubMed ID: 20524866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.